Inhibition of HIV-1 infectivity with curdlan sulfate in vitro
- 1 February 1990
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 39 (4) , 793-797
- https://doi.org/10.1016/0006-2952(90)90161-d
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- In vitro activity of mannan sulfate, a novel sulfated polysaccharide, against human immunodeficiency virus type 1 and other enveloped virusesEuropean Journal of Clinical Microbiology & Infectious Diseases, 1989
- Inhibition of HIV and virus replication by polysulphated polyxylanAIDS, 1988
- Inhibitory effect of dextran sulfate and heparin on the replication of human immunodeficiency virus (HIV) in vitroAntiviral Research, 1987
- Synthesis of new heparinoids with high anticoagulant activityJournal of Medicinal Chemistry, 1987
- Infection of HTLV-III/LAV in HTLV-I-Carrying Cells MT-2 and MT-4 and Application in a Plaque AssayScience, 1985
- Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDSScience, 1984
- Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)Science, 1983
- Pneumocystis cariniiPneumonia and Mucosal Candidiasis in Previously Healthy Homosexual MenNew England Journal of Medicine, 1981
- ULTRASTRUCTURE, DEVELOPMENT AND CYTOPLASMIC ROTATION OF SETA‐BEARING CELLS OFCOLEOCHAETE SCUTATA(CHLOROPHYCEAE)1Journal of Phycology, 1977
- Anticoagulant activity of heparin: Separation of high‐activity and low‐activity heparin species by affinity chromatography on immobilized antithrombinFEBS Letters, 1976